Amlodipine And Valsartan Tablet, Film Coated
Product Images NDC 71209-023

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 71209-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlo-vals-fig1-new1 (Amlo Vals Fig1 New1)

A line graph showing the percentage of systolic blood pressure (SBP) below 140 mmHg plotted against baseline SBP (140 to 180 mmHg). It compares four groups: Valsartan 320 mg, Amlodipine 10 mg, a combination of Amlodipine and Valsartan 10/320 mg, and placebo, with distinct markers for each group indicating their efficacy trends.*

FDA Label Image

Amlo-vals-fig2-new2 (Amlo Vals Fig2 New2)

A line graph showing the percentage of diastolic blood pressure (DBP) under 90 mmHg versus baseline DBP (mmHg). Four curves compare the effects of valsartan 320 mg, amlodipine 10 mg, amlodipine and valsartan 10/320 mg combination, and placebo. The graph illustrates treatment responses based on baseline DBP measurements.*

FDA Label Image

Amlo-vals-fig3-new3 (Amlo Vals Fig3 New3)

A line graph depicting the percentage of subjects achieving systolic blood pressure (SBP) below 130 mmHg across baseline SBP values from 140 to 180 mmHg. The graph compares four groups: Valsartan 320 mg, Amlodipine 10 mg, Amlodipine and Valsartan 10/320 mg, and Placebo, illustrating their relative efficacy in lowering SBP.*

FDA Label Image

Amlo-vals-fig4-new4 (Amlo Vals Fig4 New4)

A line graph comparing the percentage of diastolic blood pressure (DBP) readings below 80 mmHg over baseline DBP (mmHg) for four groups: Valsartan 320 mg, Amlodipine 10 mg, the combination of Amlodipine and Valsartan 10/320 mg, and Placebo. The combination treatment shows the highest percentage of DBP below 80 mmHg across baseline values.*

FDA Label Image

Amlo-vals-stru1 (Amlo Vals Stru1)

Chemical structure of the active ingredient amlodipine, showing its molecular arrangement with labeled functional groups including a chlorine-substituted phenyl ring and ester groups, consistent with the combination drug amlodipine and valsartan.*

FDA Label Image

Amlo-vals-stru2 (Amlo Vals Stru2)

Chemical structure of valsartan, an active ingredient in AMLODIPINE AND VALSARTAN tablets. The diagram shows the molecular arrangement with labeled atoms and bonds typical of valsartan's chemical formula.*

FDA Label Image

Cont-label-5mg-160mg-30 (Cont Label 5mg 160mg 30)

Label for Amlodipine and Valsartan Tablets, USP with strength 5 mg/160 mg. The film-coated tablets are manufactured by Cadila Pharmaceuticals Limited in India. The label includes storage instructions, dosage reference to the package insert, an NDC number 71209-021-01, a barcode, and notes that the product is Rx only with 30 tablets per package.*

FDA Label Image

Cont-label-5mg-160mg-90 (Cont Label 5mg 160mg 90)

Label for Amlodipine and Valsartan Tablets, USP 5 mg/160 mg, film-coated oral tablets. The label includes dosage strength, storage instructions (20°C to 25°C with permitted excursions), manufacturer Cadila Pharmaceuticals Limited, and package count of 90 tablets. It features NDC 71209-021-04 and barcode with batch and expiration date fields.*

FDA Label Image

Cont-label-10mg-160mg-30 (Cont Label 10mg 160mg 30)

Label for Amlodipine and Valsartan Tablets, USP, strength 10 mg/160 mg, film-coated tablets. The label states storage instructions, dosage note, and manufacturing details by Cadila Pharmaceuticals Limited, India. Package contains 30 tablets and includes a barcode, batch number, and expiration date fields.*

FDA Label Image

Cont-label-10mg-160mg-90 (Cont Label 10mg 160mg 90)

Label for Amlodipine and Valsartan Tablets, USP with strength 10 mg/160 mg. The label shows it is oral film-coated tablets, including storage instructions, manufacturer Cadila Pharmaceuticals Limited in India, package count of 90 tablets, and includes an NDC code and barcode. It specifies Rx only and advises dispensing the patient information leaflet.*

FDA Label Image

Cont-label-5mg-320mg-30 (Cont Label 5mg 320mg 30)

Label for Amlodipine and Valsartan Tablets, USP 5 mg/320 mg film-coated tablets. The label includes dosage form, strength, and storage instructions. It is manufactured by Cadila Pharmaceuticals Limited, India, and the package contains 30 tablets. The label also includes a barcode, batch number, and expiration date fields.*

FDA Label Image

Cont-label-5mg-320mg-90 (Cont Label 5mg 320mg 90)

Label for Amlodipine and Valsartan Tablets, USP 5 mg/320 mg by Cadila Pharmaceuticals Limited. The label indicates a film-coated tablet dosage form with a 90-tablet count. Storage instructions, manufacturer details in Ahmedabad, India, and a barcode are also visible.*

FDA Label Image

Cont-label-10mg-320mg-30 (Cont Label 10mg 320mg 30)

Label for Amlodipine and Valsartan Tablets, USP 10 mg/320 mg film-coated tablets. The label shows the NDC 71209-024-01 and states storage instructions, manufacturer Cadila Pharmaceuticals Limited, and batch/expiration date placeholders. The package contains 30 tablets for oral use, with a barcode visible.*

FDA Label Image

Cont-label-10mg-320mg-90 (Cont Label 10mg 320mg 90)

Label for Amlodipine and Valsartan Tablets, USP 10 mg/320 mg, film-coated oral tablets by Cadila Pharmaceuticals Limited. The label indicates a package of 90 tablets with storage instructions, manufacturer details in India, and a barcode. It includes standard prescription labeling and dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.